Trastuzumab TMDD to minimal-PBPK model hierarchy (Pressly 2023)
Source:vignettes/articles/Pressly_2023_trastuzumab_tmdd_tutorial.Rmd
Pressly_2023_trastuzumab_tmdd_tutorial.RmdModel and source
- Article: Pressly MA, Peletier LA, Zheng S, Sharma VD, Lien YTK, Wang W, Zhou H, Schmidt S. The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies. CPT Pharmacometrics Syst Pharmacol. 2023;12(5):639-652. https://doi.org/10.1002/psp4.12927 (PMC10196441, open access).
- Supplementary Material S1-S5 (model assumptions, the parameter table S2, flow-rate analysis, the FcRn derivation and a sensitivity analysis) and Data S1, the authors’ MATLAB code for every simulation in the paper.
Pressly 2023 is a tutorial. It builds four nested target-mediated drug disposition (TMDD) models for a monoclonal antibody, from the basic Mager and Jusko model to the minimal PBPK-TMDD model with target shedding of Li et al. (2014), and applies all four to trastuzumab with one shared parameter set (Supplementary Table S2, taken mostly from Li et al. 2014). Nothing is estimated. The simulations are compared with mean trastuzumab concentrations from the phase-I dose-escalation study of Tokuda et al. (1999).
| Paper model | Structure | In this library |
|---|---|---|
| 1 | Basic two-compartment TMDD (Eqs 1-6) | Pressly_2023_trastuzumab_tmdd |
| 2 | Model 1 with tissue resolved into vascular, endothelial, interstitial and lymph spaces (Eqs 7-12) | Pressly_2023_trastuzumab_mpbpk |
| 3 | Model 2 with quasi-steady-state FcRn recycling in the endothelium (Eqs 16-22) | Pressly_2023_trastuzumab_mpbpk_fcrn |
| 4 | Model 3 with the target moved to the interstitium as membrane-bound and shed HER2 (Eqs 23-36) | Pressly_2023_trastuzumab_mpbpk_shedding |
mods <- c(
"Pressly_2023_trastuzumab_tmdd", "Pressly_2023_trastuzumab_mpbpk",
"Pressly_2023_trastuzumab_mpbpk_fcrn", "Pressly_2023_trastuzumab_mpbpk_shedding"
)
m1 <- rxode2::rxode2(readModelDb(mods[1]))
m2 <- rxode2::rxode2(readModelDb(mods[2]))
m3 <- rxode2::rxode2(readModelDb(mods[3]))
m4 <- rxode2::rxode2(readModelDb(mods[4]))
tibble::tibble(
Model = mods,
`Paper model` = 1:4,
`ODE states` = c(length(m1$state), length(m2$state), length(m3$state), length(m4$state)),
Parameters = c(nrow(m1$iniDf), nrow(m2$iniDf), nrow(m3$iniDf), nrow(m4$iniDf))
) |>
knitr::kable()| Model | Paper model | ODE states | Parameters |
|---|---|---|---|
| Pressly_2023_trastuzumab_tmdd | 1 | 4 | 11 |
| Pressly_2023_trastuzumab_mpbpk | 2 | 7 | 20 |
| Pressly_2023_trastuzumab_mpbpk_fcrn | 3 | 7 | 25 |
| Pressly_2023_trastuzumab_mpbpk_shedding | 4 | 11 | 32 |
Population
There is no fitted population. The parameter set describes a typical
70 kg adult; the authors use the 70 kg weight only to convert the mg/kg
doses. The comparison data are the mean concentrations of Tokuda et
al. (1999), 18 Japanese patients with HER2-overexpressing metastatic
breast cancer who received single 90-min i.v. infusions of 1, 2, 4 or 8
mg/kg. The authors digitised those data and ship them in Data S1; they
are reproduced below. The source has no inter-individual variability and
no residual error, so every ini() value is
fixed() and propSd is
fixed(0).
pop <- readModelDb(mods[4])() |>
environment() |>
(\(e) e$population)()
tibble::tibble(Field = names(pop), Value = vapply(pop, \(x) paste(as.character(x), collapse = " "), "")) |>
knitr::kable()| Value |
|---|
Units and the dose conversion
Time is hours. The paper writes every equation in concentrations
(nM). In the model files the antibody states hold amounts (nmol) so that
a dose is an amount into central; each antibody equation is
the printed one multiplied through by its volume. Target and complex
states keep the printed concentrations (nM). Cc is the free
plasma antibody concentration in ug/mL (Lp * MW / 1e6), and
the free concentration in every space is also returned in nM
(lig_p, lig_v, lig_e,
lig_i, lig_s).
Supplementary Material S2 converts a mg/kg dose with a 70 kg body
weight, the molecular weight 145,532 Da and the 3 L plasma volume, so
L0 = 650 nM (the bolus of Figures 4, 6 and 8) is an amount
of 1950 nmol.
MW <- 145532 # Table S2 'MW'
VP <- 3 # Table S2 plasma volume (L)
mgkg_to_nmol <- function(mgkg, wt = 70) mgkg * wt / MW * 1e6
dose_bolus <- 650 * VP # nmol; L0 = 650 nM in Figures 4, 6, 8
tibble::tibble(
Dose = c("650 nM bolus", "1 mg/kg", "2 mg/kg", "4 mg/kg", "8 mg/kg"),
`Amount (nmol)` = c(dose_bolus, mgkg_to_nmol(c(1, 2, 4, 8))),
`Initial plasma concentration (nM)` = c(dose_bolus, mgkg_to_nmol(c(1, 2, 4, 8))) / VP
) |>
knitr::kable(digits = 1)| Dose | Amount (nmol) | Initial plasma concentration (nM) |
|---|---|---|
| 650 nM bolus | 1950 | 650.0 |
| 1 mg/kg | 481 | 160.3 |
| 2 mg/kg | 962 | 320.7 |
| 4 mg/kg | 1924 | 641.3 |
| 8 mg/kg | 3848 | 1282.7 |
Source trace
Every ini() value carries an in-file comment naming its
source. The two tables below collect them.
| Equation | Paper location | Model file |
|---|---|---|
| Free plasma antibody, Model 1 | Eq 1 (kpt Vp = ktp Vt = Cldist) |
d/dt(central), _tmdd
|
| Tissue antibody, Model 1 | Eq 2 |
d/dt(peripheral1), _tmdd
|
| Free plasma target, plasma complex | Eqs 3-4, 7 |
d/dt(target), d/dt(complex),
_tmdd to _mpbpk_fcrn
|
Baseline target R0 = ksyn/kdeg
|
Eqs 5, 6, 12, 22 | target(0) |
| Plasma antibody, Models 2-4 | Eqs 7, 16, 23 (equation images) | d/dt(central) |
| Vascular space | Eqs 8, 17, 24 | d/dt(tissue_vasc) |
| Endothelium | Eqs 9, 19, 25 | d/dt(endosome) |
| Interstitial space | Eqs 10, 20, 28 | d/dt(tissue_isf) |
| Lymph | Eqs 11, 21, 36 | d/dt(lymph) |
FcRn-bound fraction 1 - fu (QSS quadratic) |
Eq 18; Supplementary Material S4 | lig_e_bound |
| Shed target in plasma, its complex | Eq 23 |
d/dt(target), d/dt(complex),
_mpbpk_shedding
|
| Shed and membrane target in the interstitium, their complexes | Eq 28 |
d/dt(target_isf) …
d/dt(complex_mem_isf)
|
| Antibody-free baselines of the three targets | Eqs 29-30 |
target_mem_isf(0), target_isf(0),
target(0)
|
| Parameter | Value | Models | Source |
|---|---|---|---|
mw |
145,532 g/mol | 1-4 | Table S2 ‘MW’ |
lkon, lkoff
|
2.52 1/(nM h), 1.26 1/h | 1-4 | Table S2 ‘kon,p’, ‘koff,p’; ‘KD,sh = KD,m = 1.26/2.52’ |
lksyn |
0.83 nM/h | 1-3 | Table S2 ‘ksyn,p’ |
lkdeg |
0.1 1/h | 1-4 | Table S2 ‘kdeg,p’ |
lkint |
0.01 1/h | 1-4 | Table S2 ‘kint,p’ |
kel |
0 1/h | 1-4 | Table S2 ‘kel,p’ |
lvc |
3 L | 1-4 | Table S2 ‘Vc’, ‘Vp’ |
lvp |
3 L | 1 | Table S2 ‘Vp’ (tissue volume; ktp = Q/Vp) |
lq |
300 L/h | 1 | Table S2 ‘kpt = Q/Vc’, ‘ktp = Q/Vp’, ‘Q’ |
lv_tissue_vasc, lv_endosome,
lv_tissue_isf, lv_lymph
|
1.61, 0.08, 11.2, 0.2702 L | 2-4 | Table S2 ‘Vv’, ‘Ve’, ‘Vi’, ‘Vs’ |
lqc, lq_lymph
|
300, 0.119 L/h | 2-4 | Table S2 ‘Q’, ‘S’ |
sigma_v, sigma_i
|
0.9, 0.2 | 2-4 | Table S2 |
lkup, delta_kup
|
0.0298 1/h, 1 | 2-4 | Table S2 ‘kup’, ‘delta’ |
lclint |
0.01751 L/h | 2-4 | Table S2 ‘CLint’ |
lc_fcrn_t |
40,000 nM | 3-4 | Table S2 ‘FcRn’ |
lkon_fcrn, lkoff_fcrn
|
1 1/(nM h), 774 1/h | 3-4 | Table S2 ‘kon,F’, ‘koff,F’ |
fr, lkrec
|
0.715, 16.7 1/h | 3-4 | Table S2 ‘FR’, ‘krc’ (Simcyp V21) |
lksyn_mem, lkdeg_mem,
lkint_mem
|
0.83 nM/h, 0.1 1/h, 0.1 1/h | 4 | Table S2 ‘ksyn,m’, ‘kdeg,m’, ‘kint,m’ |
lksh, lkdeg_shed,
lkint_shed
|
0.138, 0.1, 0.01 1/h | 4 | Table S2 ‘ksh’, ‘kdeg,sh’, ‘kint,sh’ |
llambda_shed, alpha_shed
|
0.01 1/h, 0 | 4 | Table S2 ‘lambda’, ‘alpha’ |
The authors’ simulation code differs from the printed model
The four model files follow the printed equations and Table S2. The MATLAB code in Data S1, which produced the paper’s figures, departs from them in several places:
| Item | Printed (model files) | Data S1 code |
|---|---|---|
Model 1 plasma elimination kel
|
0 (Table S2) | 0.004 1/h (tmdd1.m,
tmdd1_data_impulse.m) |
FR |
0.715 | 0.5 (every Model 3 and 4 file) |
sigma_i |
0.2 | 0.19 (Figure 9 files for Models 3 and 4) |
KD,F = koff,F/kon,F |
774 nM | 773 nM (Figure 9 files) |
| Model 3 endothelial clearance |
fu * CLint * Le (Eq 19) |
CLint * Le, total (tmdd3*.m) |
| Model 4 shed-target transfer to plasma |
lambda * Rsh,i * Vi/Vp (Eqs 23, 30) |
lambda * Rsh,i * Ve/Vp (every Model 4 file) |
| Model 4 initial plasma shed target | Eq 30 steady state, 1.63 nM | 0 |
Model 4 kint,p
|
0.01 1/h | 0.1 1/h in tmdd4.m (Figure 8 only) |
| Initial plasma target, Figure 9, Models 1-3 |
ksyn/kdeg = 8.3 nM |
3.5 nM |
| Figure 9e-g adjustments | kup, krc, lambda as in the caption | the same, plus ksyn 0.83 -> 1 for Figure 9f |
| Infusion | 90-min i.v. infusion (text) |
D/tinf * p(t), tinf = 0.0625 with a Hill
switch-off at 0.1 h: 1.62 x the dose in about 6 min |
The library ships the printed model. The code configuration is
rebuilt below, by ini() and model() overrides,
wherever a figure is compared.
# Deposited-code configurations (Data S1). Model 2's code equals the printed model.
code_m1 <- m1 |> rxode2::ini(kel = 0.004)
code_m3 <- m3 |>
rxode2::ini(fr = 0.5, lkoff_fcrn = log(773), sigma_i = 0.19) |>
rxode2::model(
d/dt(endosome) <- kup * tissue_vasc + delta_kup * kup * tissue_isf - clint * lig_e -
krec * lig_e_bound * v_endosome
)
code_m4 <- m4 |>
rxode2::ini(fr = 0.5, lkoff_fcrn = log(773), sigma_i = 0.19) |>
rxode2::model(
d/dt(target) <- lambda_shed * target_isf * v_endosome / vc - kdeg * target -
kon * lig_p * target + koff * complex
) |>
rxode2::model(target(0) <- 0)
# The Figure 9 files also start the plasma target of Models 1-3 at 3.5 nM.
fig9_m1 <- code_m1 |> rxode2::model(target(0) <- 3.5)
fig9_m2 <- m2 |> rxode2::model(target(0) <- 3.5)
fig9_m3 <- code_m3 |> rxode2::model(target(0) <- 3.5)
# Figure 9e-g adjustments (caption values; tmdd*_data_impulse_opt.m).
fig9_m2_adj <- fig9_m2 |> rxode2::ini(lkup = log(0.00536))
fig9_m3_adj <- fig9_m3 |> rxode2::ini(lkrec = log(1.7), lksyn = log(1))
fig9_m4_adj <- code_m4 |> rxode2::ini(lkrec = log(3.13), llambda_shed = log(0.5), lkup = log(0.0298 * 1.7))
tight <- list(rtol = 1e-8, atol = 1e-10, maxsteps = 1e6, returnType = "data.frame")
solve_tight <- function(mod, ev) do.call(rxode2::rxSolve, c(list(mod, ev), tight))Didactic simulations: 650 nM bolus (Figures 4, 6 and 8)
tgrid <- sort(unique(c(seq(0, 0.2, by = 0.002), seq(0.2, 2, by = 0.02), seq(2, 1200, by = 0.5))))
ev_bolus <- dplyr::bind_rows(
data.frame(time = 0, amt = dose_bolus, evid = 1L, cmt = "central"),
data.frame(time = tgrid, amt = 0, evid = 0L, cmt = "central")
)
s1 <- solve_tight(m1, ev_bolus)
s2 <- solve_tight(m2, ev_bolus)
s3 <- solve_tight(m3, ev_bolus)
s4 <- solve_tight(m4, ev_bolus)
s3_code <- solve_tight(code_m3 |> rxode2::ini(lkoff_fcrn = log(774), sigma_i = 0.2), ev_bolus) # tmdd3.m
#> ℹ change initial estimate of `lkoff_fcrn` to `6.65157187358973`
#> ℹ change initial estimate of `sigma_i` to `0.2`
s4_code <- solve_tight(code_m4 |> rxode2::ini(lkint = log(0.1), lkoff_fcrn = log(774), sigma_i = 0.2), ev_bolus) # tmdd4.m
#> ℹ change initial estimate of `lkint` to `-2.30258509299405`
#> ℹ change initial estimate of `lkoff_fcrn` to `6.65157187358973`
#> ℹ change initial estimate of `sigma_i` to `0.2`
ligand_long <- function(s, label) {
s |>
dplyr::select(time, Lp = lig_p, Lv = lig_v, Le = lig_e, Li = lig_i, Ls = lig_s) |>
tidyr::pivot_longer(-time, names_to = "space", values_to = "conc") |>
dplyr::mutate(model = label, day = time / 24)
}
plot_ligand <- function(d, title) {
ggplot(dplyr::filter(d, conc > 1e-2), aes(day, conc, colour = space, linetype = space)) +
geom_line() +
scale_y_log10() +
coord_cartesian(xlim = c(0, 50), ylim = c(1e-2, 1e4)) +
labs(x = "Time (days)", y = "Free trastuzumab (nM)", colour = NULL, linetype = NULL, title = title)
}Model 2 (Figure 4)
The printed Model 2 and the authors’ tmdd2.m are the
same, so this replicates Figure 4 directly. The text gives four
checkpoints: plasma and vascular concentrations merge within minutes at
L = Vp/(Vp + Vv) L0 = 423 nM; the endothelial concentration
climbs to about twice that; the plasma profile falls steeply at about
7.5 days; and while the target stays saturated the complex climbs toward
R* = ksyn/kint = 83 nM (Eq 15).
plot_ligand(ligand_long(s2, "Model 2"), "Model 2, L0 = 650 nM")
ggplot(s2, aes(time / 24)) +
geom_line(aes(y = target, colour = "Rp")) +
geom_line(aes(y = complex, colour = "LRp")) +
coord_cartesian(xlim = c(0, 50)) +
labs(x = "Time (days)", y = "Concentration (nM)", colour = NULL,
caption = "Replicates Figure 4 of Pressly 2023.")
lbar <- VP / (VP + 1.61) * 650
lp_mixed <- s2$lig_p[s2$time == 0.1]
le_peak <- max(s2$lig_e)
lrp_peak_day <- s2$time[which.max(s2$complex)] / 24
c(L_bar = lbar, Lp_6min = lp_mixed, Le_peak = le_peak, LRp_peak = max(s2$complex), LRp_peak_day = lrp_peak_day)
#> L_bar Lp_6min Le_peak LRp_peak LRp_peak_day
#> 422.9935 416.9825 1007.6577 63.2222 6.8125
stopifnot(
abs(lbar - 423) < 0.5, # Supplementary Material S3: L = 0.651 x 650 = 423 nM
# Lp after mixing sits below L by the drug bound to the 8.3 nM target.
abs(lp_mixed / lbar - 1) < 0.02,
le_peak / lbar > 2 && le_peak / lbar < 2.6, # 'about twice'; Figure 4a peak ~1000 nM
max(s2$complex) < 0.83 / 0.01, # bounded by R* = 83 nM (Eq 15)
abs(max(s2$complex) - 63) < 3, # Figure 4c peak ~63 nM
abs(lrp_peak_day - 7) < 1 # 'peaking around day 7 in model 2'
)Model 3 (Figure 6)
Figure 6 was drawn by tmdd3.m, which recycles with
FR = 0.5 and clears total rather than FcRn-unbound
endothelial antibody. Both are shown. In both, FcRn protection holds the
complex near its R* plateau for weeks instead of the single
day-7 peak of Model 2, as the text describes.
dplyr::bind_rows(ligand_long(s3, "printed (library)"), ligand_long(s3_code, "deposited code")) |>
dplyr::filter(space %in% c("Lp", "Le", "Li")) |>
ggplot(aes(day, conc, colour = space, linetype = model)) +
geom_line() +
scale_y_log10() +
coord_cartesian(xlim = c(0, 50), ylim = c(1e-2, 1e4)) +
labs(x = "Time (days)", y = "Free trastuzumab (nM)", colour = NULL, linetype = NULL,
caption = "Compare Figure 6b of Pressly 2023 (deposited-code curves).")
#> Warning in scale_y_log10(): log-10 transformation introduced infinite values.
landmarks <- function(s, label) {
tibble::tibble(
Configuration = label,
`Lp day 10 (nM)` = s$lig_p[s$time == 240],
`Lp day 30 (nM)` = s$lig_p[s$time == 720],
`LRp max (nM)` = max(s$complex),
`Day Lp < 1 nM` = s$time[which(s$lig_p < 1)[1]] / 24
)
}
lm3 <- dplyr::bind_rows(landmarks(s2, "Model 2"), landmarks(s3, "Model 3 printed"), landmarks(s3_code, "Model 3 code"))
knitr::kable(lm3, digits = 2)| Configuration | Lp day 10 (nM) | Lp day 30 (nM) | LRp max (nM) | Day Lp < 1 nM |
|---|---|---|---|---|
| Model 2 | 2.50 | 0.02 | 63.22 | 13.62 |
| Model 3 printed | 240.54 | 33.47 | 80.00 | 40.67 |
| Model 3 code | 200.58 | 12.90 | 79.39 | 38.65 |
Model 4 (Figure 8)
Supplementary Material S5.3 gives the antibody-free steady state of
the interstitial targets as Rm,ss = 3.49 and
Rs,ss = 4.37 nM (Eq 29); the model starts there. It prints
Rp,ss = 0.093 nM for the plasma shed target, which neither
the printed Eq 30 (1.63 nM) nor the code (0) gives; it matches the
authors’ tmddPBPK4aaa.m formula
lambda/kdeg * Rm * Vp/Vi. Figure 8 was drawn by
tmdd4.m (Ve/Vp transfer, plasma shed target
starting at 0, kint,p = 0.1), which leaves almost no free
target in plasma.
dplyr::bind_rows(ligand_long(s4, "printed (library)"), ligand_long(s4_code, "deposited code")) |>
dplyr::filter(space %in% c("Lp", "Le", "Li")) |>
ggplot(aes(day, conc, colour = space, linetype = model)) +
geom_line() +
scale_y_log10() +
coord_cartesian(xlim = c(0, 50), ylim = c(1e-2, 1e4)) +
labs(x = "Time (days)", y = "Free trastuzumab (nM)", colour = NULL, linetype = NULL,
caption = "Compare Figure 8b of Pressly 2023 (deposited-code curves).")
#> Warning in scale_y_log10(): log-10 transformation introduced infinite values.
dplyr::bind_rows(
s4 |> dplyr::mutate(model = "printed (library)"),
s4_code |> dplyr::mutate(model = "deposited code")
) |>
dplyr::select(time, model, Rs = target_isf, LRs = complex_isf, Rm = target_mem_isf, LRm = complex_mem_isf) |>
tidyr::pivot_longer(c(Rs, LRs, Rm, LRm), names_to = "species", values_to = "conc") |>
ggplot(aes(time / 24, conc, colour = species, linetype = model)) +
geom_line() +
coord_cartesian(xlim = c(0, 50)) +
labs(x = "Time (days)", y = "Interstitial target (nM)", colour = NULL, linetype = NULL,
caption = "Compare Figure 8c of Pressly 2023.")
c(Rm0 = s4$target_mem_isf[1], Rs0 = s4$target_isf[1], Rp0 = s4$target[1],
LRm_peak = max(s4$complex_mem_isf), LRm_peak_code = max(s4_code$complex_mem_isf))
#> Rm0 Rs0 Rp0 LRm_peak LRm_peak_code
#> 3.487395 4.375095 1.633369 6.025472 7.222965
stopifnot(
abs(s4$target_mem_isf[1] - 3.49) < 0.005, # S5.3 Rm,ss = 3.49 nM
abs(s4$target_isf[1] - 4.37) < 0.01, # S5.3 Rs,ss = 4.37 nM
abs(s4$target[1] - 0.01 / 0.1 * s4$target_isf[1] * 11.2 / 3) < 1e-6, # Eq 30
abs(max(s4_code$complex_mem_isf) - 7.2) < 0.4 # Figure 8c LRm peak ~7.2 nM
)Antibody mass balance
Each model loses antibody only through the printed elimination terms:
complex internalisation in plasma (kint), endothelial
clearance (CLint, Models 2-4), and in Model 4
internalisation of the two interstitial complexes. The antibody left in
the states plus the integrated elimination must equal the dose.
cum_trapz <- function(t, f) c(0, cumsum(diff(t) * (head(f, -1) + tail(f, -1)) / 2))
closure <- function(s, drug, flux) max(abs((drug + cum_trapz(s$time, flux)) / dose_bolus - 1))
mb <- c(
`Model 1` = closure(s1, with(s1, central + peripheral1 + 3 * complex), with(s1, 0.01 * 3 * complex)),
`Model 2` = closure(
s2, with(s2, central + tissue_vasc + endosome + tissue_isf + lymph + 3 * complex),
with(s2, 0.01 * 3 * complex + 0.01751 * lig_e)
),
`Model 3` = closure(
s3, with(s3, central + tissue_vasc + endosome + tissue_isf + lymph + 3 * complex),
with(s3, 0.01 * 3 * complex + 0.01751 * lig_e_free)
),
`Model 4` = closure(
s4, with(s4, central + tissue_vasc + endosome + tissue_isf + lymph + 3 * complex +
11.2 * (complex_isf + complex_mem_isf)),
with(s4, 0.01 * 3 * complex + 0.01751 * lig_e_free + 11.2 * (0.01 * complex_isf + 0.1 * complex_mem_isf))
)
)
mb
#> Model 1 Model 2 Model 3 Model 4
#> 4.180703e-07 3.168164e-05 3.670304e-07 5.025482e-06
stopifnot(all(mb < 1e-3))Trastuzumab case study (Figure 9)
Data
# Tokuda 1999 mean concentrations as digitised by the authors (Data S1,
# tmdd*_data_impulse.m). The code labels them ng/L; the values are ng/mL
# (the 8 mg/kg peak of 165,691 is 166 ug/mL).
tokuda <- dplyr::bind_rows(
tibble::tibble(
mgkg = 1, day = c(0.05, 0.08, 0.09, 0.27, 0.50, 1.06, 2.05, 3.04, 7.03, 9.97, 13.99, 21.01),
ngmL = c(59, 2532, 6882, 18146, 15438, 12872, 9412, 8254, 3131, 960, 301, 55)
),
tibble::tibble(
mgkg = 2, day = c(0.06, 0.09, 0.16, 0.31, 0.52, 1.06, 2.13, 3.04, 7.03, 9.98, 14.02, 21.05),
ngmL = c(4882, 16075, 48329, 43687, 37927, 31944, 23123, 17427, 9702, 4982, 2408, 562)
),
tibble::tibble(
mgkg = 4, day = c(0.03, 0.11, 0.16, 0.30, 0.52, 1.06, 2.08, 3.07, 7.03, 10.01, 14.08, 21.06),
ngmL = c(10625, 23357, 67445, 62841, 60353, 52928, 48820, 43248, 25323, 19872, 19673, 8508)
),
tibble::tibble(
mgkg = 8, day = c(0.14, 0.33, 0.53, 1.05, 2.07, 3.05, 7.03, 10.06, 14.04, 21.16),
ngmL = c(143845, 165691, 151295, 124880, 111750, 83378, 62210, 45949, 37169, 25839)
)
) |>
dplyr::mutate(treatment = paste(mgkg, "mg/kg"), Cc = ngmL / 1000)Dosing
The text describes a 90-min infusion, which is how the library models
are dosed here. The Figure 9 code instead adds
D/tinf * p(t) to the plasma equation with
tinf = 0.0625 and
p(t) = 1 - t^12/(0.1^12 + t^12) (t in hours): a
near-rectangular input that switches off at 0.1 h and delivers
integral(p)/tinf = 1.62 times the dose. The code
configuration reproduces that input as a zero-order infusion of the same
rate and total amount.
p_int <- integrate(function(t) 1 - t^12 / (0.1^12 + t^12), 0, Inf)$value
code_factor <- p_int / 0.0625
code_factor
#> [1] 1.618424
stopifnot(abs(code_factor - 1.6184) < 1e-3)
obs_h <- sort(unique(c(seq(0, 2, by = 0.02), seq(2, 50 * 24, by = 1), tokuda$day * 24)))
make_dose_group <- function(i, mgkg, amt, dur) {
dplyr::bind_rows(
data.frame(id = i, time = 0, amt = amt, dur = dur, evid = 1L, cmt = "central"),
data.frame(id = i, time = obs_h, amt = 0, dur = 0, evid = 0L, cmt = "central")
) |>
dplyr::mutate(mgkg = mgkg, treatment = paste(mgkg, "mg/kg"))
}
doses <- c(1, 2, 4, 8)
ev_paper <- dplyr::bind_rows(lapply(seq_along(doses), function(i) {
make_dose_group(i, doses[i], mgkg_to_nmol(doses[i]), 1.5)
}))
ev_code <- dplyr::bind_rows(lapply(seq_along(doses), function(i) {
make_dose_group(i, doses[i], mgkg_to_nmol(doses[i]) * code_factor, 0.0625 * code_factor)
}))
stopifnot(!anyDuplicated(ev_paper[ev_paper$evid == 0, c("id", "time")]))Simulations
# warning = FALSE: rxode2 warns that a multi-subject solve has no omega; these
# models have no between-subject variability by design.
fig9_solve <- function(mod, ev, label) {
do.call(rxode2::rxSolve, c(list(mod, ev, keep = c("treatment", "mgkg")), tight)) |>
dplyr::mutate(config = label)
}
sim9 <- dplyr::bind_rows(
fig9_solve(m1, ev_paper, "Model 1 library"),
fig9_solve(m2, ev_paper, "Model 2 library"),
fig9_solve(m3, ev_paper, "Model 3 library"),
fig9_solve(m4, ev_paper, "Model 4 library"),
fig9_solve(fig9_m1, ev_code, "9a Model 1 code"),
fig9_solve(fig9_m2, ev_code, "9b Model 2 code"),
fig9_solve(fig9_m3, ev_code, "9c Model 3 code"),
fig9_solve(code_m4, ev_code, "9d Model 4 code"),
fig9_solve(fig9_m2_adj, ev_code, "9e Model 2 adjusted"),
fig9_solve(fig9_m3_adj, ev_code, "9f Model 3 adjusted"),
fig9_solve(fig9_m4_adj, ev_code, "9g Model 4 adjusted")
)
stopifnot(!anyNA(sim9$Cc), all(sim9$Cc >= -1e-6 * max(sim9$Cc)))
ggplot(dplyr::filter(sim9, grepl("library", config), time > 0, time <= 25 * 24),
aes(time / 24, Cc * 1000, colour = treatment)) +
geom_line() +
geom_point(data = tokuda, aes(day, ngmL), shape = 1) +
facet_wrap(~config) +
scale_y_log10(limits = c(1e-2, 1e6)) +
labs(x = "Time (days)", y = "Free trastuzumab (ng/mL)", colour = NULL,
caption = "Library models (printed equations, Table S2) with a 90-min infusion; circles: Tokuda 1999.")
ggplot(dplyr::filter(sim9, !grepl("library", config), time > 0, time <= 25 * 24),
aes(time / 24, Cc * 1000, colour = treatment)) +
geom_line() +
geom_point(data = tokuda, aes(day, ngmL), shape = 1) +
facet_wrap(~config, ncol = 2) +
scale_y_log10(limits = c(1e-2, 1e6)) +
labs(x = "Time (days)", y = "Free trastuzumab (ng/mL)", colour = NULL,
caption = "Replicates Figure 9a-g of Pressly 2023 (deposited-code configuration); circles: Tokuda 1999.")
Fit to the Tokuda data
The paper’s conclusions on Figure 9 are qualitative: Model 1 “captures the clinical data very well”, Models 2-4 do worse with the shared parameters, and each adjustment improves the fit. The table scores each configuration by the root-mean-square log error against the Tokuda means after the infusion (day > 0.2), and the day-21 prediction per dose.
pred_at <- sim9 |>
dplyr::select(config, treatment, time, Cc) |>
dplyr::inner_join(tokuda |> dplyr::mutate(time = day * 24) |> dplyr::select(treatment, time, day, obs = Cc),
by = c("treatment", "time"))
stopifnot(nrow(pred_at) == nrow(tokuda) * length(unique(sim9$config)))
score <- pred_at |>
dplyr::filter(day > 0.2) |>
dplyr::group_by(config) |>
dplyr::summarise(rms_log = sqrt(mean(log(Cc / obs)^2)), .groups = "drop")
day21 <- sim9 |>
dplyr::filter(time == 21 * 24) |>
dplyr::select(config, treatment, Cc) |>
dplyr::mutate(Cc = signif(Cc * 1000, 3)) |>
tidyr::pivot_wider(names_from = treatment, values_from = Cc)
score_tab <- dplyr::left_join(score, day21, by = "config")
score_tab |>
dplyr::rename(Configuration = config, `RMS log error` = rms_log) |>
knitr::kable(digits = 2, caption = "Day-21 columns: free trastuzumab (ng/mL). Tokuda day 21: 55 / 562 / 8508 / 25839 ng/mL.")| Configuration | RMS log error | 1 mg/kg | 2 mg/kg | 4 mg/kg | 8 mg/kg |
|---|---|---|---|---|---|
| 9a Model 1 code | 0.39 | 59.60 | 304.0 | 8910.0 | 36100.0 |
| 9b Model 2 code | 2.20 | 10.50 | 19.6 | 36.0 | 65.7 |
| 9c Model 3 code | 0.89 | 128.00 | 5510.0 | 37900.0 | 104000.0 |
| 9d Model 4 code | 0.73 | 564.00 | 1210.0 | 4110.0 | 43000.0 |
| 9e Model 2 adjusted | 0.44 | 53.90 | 224.0 | 4640.0 | 27500.0 |
| 9f Model 3 adjusted | 0.41 | 45.50 | 222.0 | 7390.0 | 38700.0 |
| 9g Model 4 adjusted | 0.50 | 103.00 | 269.0 | 1750.0 | 40000.0 |
| Model 1 library | 0.46 | 36.50 | 262.0 | 16300.0 | 62500.0 |
| Model 2 library | 2.57 | 6.85 | 12.9 | 23.9 | 43.7 |
| Model 3 library | 0.43 | 36.80 | 263.0 | 17400.0 | 67800.0 |
| Model 4 library | 0.44 | 154.00 | 529.0 | 2630.0 | 12400.0 |
rms <- setNames(score$rms_log, score$config)
d21_8 <- setNames(day21$`8 mg/kg`, day21$config)
stopifnot(
# Figure 9a: the code configuration of Model 1 tracks the data
# (measured 0.39; the 8 mg/kg day-21 value is 1.4x the observed mean).
rms[["9a Model 1 code"]] < 0.45,
d21_8[["9a Model 1 code"]] < 1.5 * 25839,
# Each Figure 9e-g adjustment improves on its unadjusted panel, as the text
# says (measured 2.20 -> 0.44, 0.89 -> 0.41, 0.73 -> 0.50).
rms[["9e Model 2 adjusted"]] < rms[["9b Model 2 code"]] / 3,
rms[["9f Model 3 adjusted"]] < rms[["9c Model 3 code"]] / 1.5,
rms[["9g Model 4 adjusted"]] < rms[["9d Model 4 code"]],
# With the tabulated kel = 0 the library Model 1 has no linear clearance,
# so at 8 mg/kg, where the target is saturated, it holds the antibody too
# long (measured 62,500 ng/mL at day 21, 2.4x the observed mean).
d21_8[["Model 1 library"]] > 2 * 25839,
# Model 2 with the shared parameters clears far too fast whichever input
# is used (Figure 9b).
rms[["Model 2 library"]] > 2,
rms[["9b Model 2 code"]] > 2
)Two effects separate the library rows from the Figure 9 rows. The
first is the input: the Figure 9 code delivers 1.62 times the stated
dose, so with the dose actually given in the Tokuda study the library
Models 3 and 4 sit closer to the data than their Figure 9c and 9d panels
(RMS log error 0.43 and 0.44 against 0.89 and 0.73). The second is the
set of code deviations tabulated above. Model 1 shows both: with
kel = 0 and the true dose its overall error is similar to
Figure 9a, but its 8 mg/kg profile stays too high once the target is
saturated, because nothing but the target removes the antibody. Model 2
has the same structure in the library and in the code, so its two rows
differ by the input alone.
PKNCA: clearance against Tokuda 1999
Tokuda et al. report trastuzumab clearance falling from 14.1
mL/kg/day at 1 mg/kg to 5.6 mL/kg/day at 8 mg/kg, which the paper quotes
as the nonlinearity the models must capture. PKNCA computes
dose/AUC0-inf on the free plasma profiles of each library
model with the 90-min infusion, simulated for 50 days.
nca_conc <- sim9 |>
dplyr::filter(grepl("library", config), mgkg %in% c(1, 8), !is.na(Cc)) |>
dplyr::mutate(day = time / 24, Cc = pmax(Cc, 0)) |>
dplyr::select(config, treatment, id, day, Cc)
stopifnot(all(nca_conc$day[!duplicated(nca_conc[, c("config", "id")])] == 0))
nca_dose <- nca_conc |>
dplyr::distinct(config, treatment, id) |>
dplyr::mutate(day = 0, amt = as.numeric(sub(" mg/kg", "", treatment)))
o_conc <- PKNCA::PKNCAconc(nca_conc, Cc ~ day | config + treatment + id)
o_dose <- PKNCA::PKNCAdose(nca_dose, amt ~ day | config + treatment + id, route = "intravascular", duration = 1.5 / 24)
intervals <- data.frame(start = 0, end = Inf, cmax = TRUE, aucinf.obs = TRUE, cl.obs = TRUE)
nca <- PKNCA::pk.nca(PKNCA::PKNCAdata(o_conc, o_dose, intervals = intervals))
# cl.obs is (mg/kg) / (ug*day/mL) = L/day/kg; convert to mL/day/kg.
sim_cl <- as.data.frame(nca) |>
dplyr::filter(PPTESTCD == "cl.obs") |>
dplyr::transmute(config, treatment, PPTESTCD, PPORRES = PPORRES * 1000)
stopifnot(nrow(sim_cl) == 8L, !anyNA(sim_cl$PPORRES))
published_cl <- tidyr::expand_grid(
config = unique(sim_cl$config),
tibble::tibble(treatment = c("1 mg/kg", "8 mg/kg"), cl.obs = c(14.1, 5.6))
)
cmp <- nlmixr2lib::ncaComparisonTable(
simulated = sim_cl,
reference = published_cl,
by = c("config", "treatment"),
units = c(cl.obs = "mL/day/kg"),
tolerance_pct = 20
)
# ncaParamLabel() names cl.obs 'CL/F'; the dose here is intravenous.
cmp |>
dplyr::mutate(`NCA parameter` = sub("CL/F", "CL", `NCA parameter`, fixed = TRUE)) |>
knitr::kable(caption = "Free-antibody clearance, library models vs. Tokuda 1999. * differs from the reference by >20%.")| NCA parameter | config | treatment | Reference | Simulated | % diff |
|---|---|---|---|---|---|
| CL (mL/day/kg) | Model 1 library | 1 mg/kg | 14.1 | 20.6 | +45.9%* |
| CL (mL/day/kg) | Model 1 library | 8 mg/kg | 5.6 | 2.52 | -55.0%* |
| CL (mL/day/kg) | Model 2 library | 1 mg/kg | 14.1 | 39 | +176.3%* |
| CL (mL/day/kg) | Model 2 library | 8 mg/kg | 5.6 | 23.2 | +314.3%* |
| CL (mL/day/kg) | Model 3 library | 1 mg/kg | 14.1 | 18.8 | +33.3%* |
| CL (mL/day/kg) | Model 3 library | 8 mg/kg | 5.6 | 2.32 | -58.6%* |
| CL (mL/day/kg) | Model 4 library | 1 mg/kg | 14.1 | 11.8 | -16.5% |
| CL (mL/day/kg) | Model 4 library | 8 mg/kg | 5.6 | 6.77 | +20.9%* |
cl <- tidyr::pivot_wider(sim_cl, names_from = treatment, values_from = PPORRES)
cl
#> # A tibble: 4 × 4
#> config PPTESTCD `1 mg/kg` `8 mg/kg`
#> <chr> <chr> <dbl> <dbl>
#> 1 Model 1 library cl.obs 20.6 2.52
#> 2 Model 2 library cl.obs 39.0 23.2
#> 3 Model 3 library cl.obs 18.8 2.32
#> 4 Model 4 library cl.obs 11.8 6.77
# Every model reproduces the direction of the nonlinearity: clearance falls
# with dose because the target saturates.
cl_at <- function(cfg, dose) cl[[dose]][cl$config == cfg]
stopifnot(
all(cl$`1 mg/kg` > cl$`8 mg/kg`),
# Measured: Model 2 39.0 / 23.2; Models 1 and 3 2.5 and 2.3 at 8 mg/kg;
# Model 4 11.8 / 6.8 mL/day/kg (Tokuda: 14.1 / 5.6).
cl_at("Model 2 library", "1 mg/kg") > 2 * 14.1,
cl_at("Model 1 library", "8 mg/kg") < 5.6 / 2,
cl_at("Model 3 library", "8 mg/kg") < 5.6 / 2,
abs(cl_at("Model 4 library", "1 mg/kg") / 14.1 - 1) < 0.25,
abs(cl_at("Model 4 library", "8 mg/kg") / 5.6 - 1) < 0.25
)The starred rows are expected: none of the four models was fitted.
All four reproduce the direction of the nonlinearity. Model 2 clears 2-4
times too fast, as Figure 9b shows. Models 1 and 3 overshoot the fall in
clearance, since with kel = 0 (Model 1) or strong FcRn
protection (Model 3) little but the saturable target removes antibody at
8 mg/kg. Model 4, whose interstitial target and endothelial clearance
both act, comes closest to both reported values.
Assumptions and deviations
- Printed model, not the simulation code. The model files follow the printed equations and Supplementary Table S2. The authors’ MATLAB code differs in the places tabulated above. The maintainers ruled that the paper’s own parameter table and equations take precedence; the code configuration is rebuilt in this article for every figure comparison. As a result, the library models do not reproduce the adjusted Figure 9f and 9g panels; the code configurations do.
-
Model 1 has no linear elimination. Table S2 lists
kel,p = 0, and the library keeps it, so free antibody leaves Model 1 only through the target. Every Model 1 simulation in the paper, including Figure 9a, usedkel = 0.0041/h; useini(kel = 0.004)to reproduce them. Because the tabulated value is zero,kelis carried untransformed in all four files (a log-scalelkelcannot hold 0), and the convention checker’s log-transform warning on it is expected. -
Typographical points in the source. Eq 20 prints
(1 - sigma_v) L * Lvwhere the lymph flowSis meant (as in Eqs 10 and 28). Table S2 labels bothVcandVp“Volume of plasma compartment”; withkpt = Q/Vcandktp = Q/Vp,Vpthere is the Model 1 tissue volume. Table S2 givesFRthe unit 1/h; it is a fraction. Supplementary Material S5.3 printsRp,ss = 0.093nM, inconsistent with Eq 30 (see the Model 4 section). -
Shared binding constants. Table S2 defines
KD,sh = KD,maskoff,p/kon,pand the text setskon,sh = kon,m,koff,sh = koff,m. Model 4 therefore uses onekon/koffpair for all three binding reactions. -
Free, not total, antibody.
Ccis free plasma antibody, which is what the authors plot against the Tokuda data. The Tokuda assay measured serum trastuzumab, presumably total; with nM target concentrations against uM antibody the difference is small at the doses studied. - Dosing. Library comparisons use the 90-min infusion stated in the text; the code configurations use the code’s 6-min, 1.62-fold input (see Dosing). The code’s endothelial initial value of 5.1e-5 nM in Model 4, there to avoid a division by zero in the FcRn fraction, is not reproduced; the library form of the FcRn quadratic has no singularity at zero.
-
No variability or residual error.
propSdisfixed(0)in all four files. -
Integrator. The authors used MATLAB
ode15s/ode23s; here the models are solved with LSODA at tight tolerances.